Personal information

Other IDs

Scopus Author ID: 26029719600
Loop profile: 893631

Keywords

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, MGUS, Lymphoma

Countries

Italy

Activities

Collapse all

Works (50 of 256)

Items per page:
Page 1 of 6

Significant Advancements and Evolutions in Chimeric Antigen Receptor Design

International Journal of Molecular Sciences
2024-11 | Journal article | Author
DOI: 10.3390/ijms252212201
Contributors: Anna Gaimari; Anna De Lucia; Fabio Nicolini; Lucia Mazzotti; ROBERTA MALTONI; Giovanna Rughi; Matteo Zurlo; Matteo Marchesini; Manel Juan; Daniel Parras et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia

Hematology Reports
2024-04-30 | Journal article
DOI: 10.3390/hematolrep16020027
Contributors: Samir Mouhssine; Nawar Maher; Sreekar Kogila; Claudio Cerchione; Giovanni Martinelli; Gianluca Gaidano
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma

Cancers
2024-02-18 | Journal article
DOI: 10.3390/cancers16040826
Contributors: Andrea Duminuco; Gabriella Santuccio; Annalisa Chiarenza; Amalia Figuera; Giovanna Motta; Anastasia Laura Caruso; Alessandro Petronaci; Massimo Ippolito; Claudio Cerchione; Francesco Di Raimondo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

How I Manage Chronic Lymphocytic Leukemia

Hematology Reports
2023-08-01 | Journal article
DOI: 10.3390/hematolrep15030047
Contributors: Patrice Nasnas; Claudio Cerchione; Gerardo Musuraca; Giovanni Martinelli; Alessandra Ferrajoli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon

International Journal of Molecular Sciences
2022-11 | Journal article | Author
DOI: 10.3390/ijms232113332
Contributors: Massimo Martino; Virginia Naso; Barbara Loteta; Filippo Antonio Canale; Marta Pugliese; Caterina Alati; Gerardo Musuraca; Davide Nappi; Anna Gaimari; Fabio Nicolini et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Pegfilgrastim in Supportive Care of Hodgkin Lymphoma

Cancers
2022-08-23 | Journal article
DOI: 10.3390/cancers14174063
Contributors: Claudio Cerchione; Davide Nappi; Alessandra Romano; Giovanni Martinelli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

International Journal of Molecular Sciences
2022-08-02 | Journal article
DOI: 10.3390/ijms23158590
Contributors: Lucia Mazzotti; Anna Gaimari; Sara Bravaccini; Roberta Maltoni; Claudio Cerchione; Manel Juan; Europa Azucena-Gonzalez Navarro; Anna Pasetto; Daniela Nascimento Silva; Valentina Ancarani et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol

Cancers
2022-06 | Journal article | Author
DOI: 10.3390/cancers14123012
Contributors: Monica Messina; Alfonso Piciocchi; Tiziana Ottone; Stefania Paolini; Cristina Papayannidis; Federica Lessi; Nicola Stefano Fracchiolla; Fabio Forghieri; anna candoni; Andrea Mengarelli et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection

Cancers
2022-02-24 | Journal article
DOI: 10.3390/cancers14051173
Contributors: Alessandra Romano; Claudio Cerchione; Concetta Conticello; Sabina Filetti; Anna Bulla; Annalisa Chiarenza; Vittorio Del Fabro; Salvatore Leotta; Uros Markovic; Giovanna Motta et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.684396
EID:

2-s2.0-85108065422

Part of ISSN: 2234943X
Contributors: Simonetti, G.; Angeli, D.; Petracci, E.; Fonzi, E.; Vedovato, S.; Sperotto, A.; Padella, A.; Ghetti, M.; Ferrari, A.; Robustelli, V. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2020.624573
EID:

2-s2.0-85101075178

Part of ISSN: 2234943X
Contributors: Kaufman, G.P.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Car t cells targeting options in the fight against multiple myeloma

Panminerva Medica
2021 | Journal article
DOI: 10.23736/S0031-0808.20.04146-4
EID:

2-s2.0-85100880952

Part of ISSN: 18271898 00310808
Contributors: Nicolini, F.; Bravaccini, S.; Mazza, M.; Gruszka, A.M.; Tazzari, M.; Martín-Antonio, B.; Juan, M.; Ibrahim, T.; Maltoni, R.; Martinelli, G. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

Journal of Medical Virology
2021 | Journal article
DOI: 10.1002/jmv.26217
EID:

2-s2.0-85087447353

Part of ISSN: 10969071 01466615
Contributors: Lucchesi, A.; Silimbani, P.; Musuraca, G.; Cerchione, C.; Martinelli, G.; Di Carlo, P.; Napolitano, M.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667-671”

European Journal of Haematology
2021 | Journal article
DOI: 10.1111/ejh.13558
EID:

2-s2.0-85101869761

Part of ISSN: 16000609 09024441
Contributors: Picardi, M.; Giordano, C.; Della Pepa, R.; Cerchione, C.; Pugliese, N.; Leone, A.; Vitiello, S.; Pane, F.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2020.624661
EID:

2-s2.0-85101972978

Part of ISSN: 2234943X
Contributors: Offidani, M.; Corvatta, L.; Morè, S.; Nappi, D.; Martinelli, G.; Olivieri, A.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.632231
EID:

2-s2.0-85103850199

Part of ISSN: 2234943X
Contributors: Cerchione, C.; Locatelli, F.; Martinelli, G.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Haematologica
2021 | Journal article
DOI: 10.3324/haematol.2019.241513
EID:

2-s2.0-85099006875

Part of ISSN: 15928721 03906078
Contributors: Gentile, M.; Specchia, G.; Derudas, D.; Galli, M.; Botta, C.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangiacavalli, S. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells

Cell Biology and Toxicology
2021 | Journal article
DOI: 10.1007/s10565-021-09640-x
EID:

2-s2.0-85114867301

Part of ISSN: 15736822 07422091
Contributors: Ghelli Luserna Di Rorà, A.; Ghetti, M.; Ledda, L.; Ferrari, A.; Bocconcelli, M.; Padella, A.; Napolitano, R.; Fontana, M.C.; Liverani, C.; Imbrogno, E. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

PloS one
2021 | Journal article
DOI: 10.1371/journal.pone.0247093
EID:

2-s2.0-85101719127

Part of ISSN: 19326203
Contributors: Mosquera Orgueira, A.; Peleteiro Raíndo, A.; Cid López, M.; Antelo Rodríguez, B.; Díaz Arias, J.Á.; Ferreiro Ferro, R.; Alonso Vence, N.; Bendaña López, Á.; Abuín Blanco, A.; Bao Pérez, L. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.639387
EID:

2-s2.0-85105008222

Part of ISSN: 2234943X
Contributors: Cerchione, C.; Romano, A.; Daver, N.; DiNardo, C.; Jabbour, E.J.; Konopleva, M.; Ravandi-Kashani, F.; Kadia, T.; Martelli, M.P.; Isidori, A. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Immunotherapy in Acute Myeloid Leukemia: Where We Stand

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.656218
EID:

2-s2.0-85107236160

Part of ISSN: 2234943X
Contributors: Isidori, A.; Cerchione, C.; Daver, N.; DiNardo, C.; Garcia-Manero, G.; Konopleva, M.; Jabbour, E.; Ravandi, F.; Kadia, T.; Burguera, A.D.L.F. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.657191
EID:

2-s2.0-85104033641

Part of ISSN: 2234943X
Contributors: Mosquera Orgueira, A.; Peleteiro Raíndo, A.; Cid López, M.; Díaz Arias, J.Á.; González Pérez, M.S.; Antelo Rodríguez, B.; Alonso Vence, N.; Bao Pérez, L.; Ferreiro Ferro, R.; Albors Ferreiro, M. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

PET/CT in Multiple Myeloma: Beyond FDG

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2020.622501
EID:

2-s2.0-85100646099

Part of ISSN: 2234943X
Contributors: Matteucci, F.; Paganelli, G.; Martinelli, G.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial

Annals of Hematology
2021 | Journal article
DOI: 10.1007/s00277-021-04537-5
EID:

2-s2.0-85105387193

Part of ISSN: 14320584 09395555
Contributors: Picardi, M.; Cavaliere, C.; Della Pepa, R.; Nicolai, E.; Soricelli, A.; Giordano, C.; Pugliese, N.; Rascato, M.G.; Cappuccio, I.; Campagna, G. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia

Expert Opinion on Drug Safety
2021 | Journal article
DOI: 10.1080/14740338.2021.1913120
EID:

2-s2.0-85104471973

Part of ISSN: 1744764X 14740338
Contributors: Marconi, G.; Giannini, M.B.; Bagnato, G.; Simonetti, G.; Cerchione, C.; Mosquera Orgueira, A.; Musuraca, G.; Martinelli, G.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.643490
EID:

2-s2.0-85104997979

Part of ISSN: 2234943X
Contributors: Botta, C.; Martino, E.A.; Conticello, C.; Mendicino, F.; Vigna, E.; Romano, A.; Palumbo, G.A.; Cerchione, C.; Martinelli, G.; Morabito, F. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Urinary Biomarkers in Tumors: An Overview

Methods in Molecular Biology
2021 | Book chapter
DOI: 10.1007/978-1-0716-1354-2_1
EID:

2-s2.0-85102148075

Part of ISSN: 19406029 10643745
Contributors: Cimmino, I.; Bravaccini, S.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma

Supportive Care in Cancer
2021-11-14 | Journal article
DOI: 10.1007/s00520-021-06266-x
Contributors: Claudio Cerchione; Davide Nappi; Giovanni Martinelli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin

Cancers
2021-09 | Journal article | Author
DOI: 10.3390/cancers13184566
Contributors: Michele Gottardi; GIORGIA SIMONETTI; Alessandra Sperotto; Davide Nappi; Andrea Ghelli Luserna di Rorà; Antonella Padella; Marianna Norata; Maria Benedetta Giannini; Gerardo Musuraca; Francesco Lanza et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Safety of FLT3 inhibitors in patients with acute myeloid leukemia

Expert Review of Hematology
2021-09-02 | Journal article
DOI: 10.1080/17474086.2021.1969911
Contributors: Claudio Cerchione; Andrés Peleteiro Raíndo; Adrián Mosquera Orgueira; Alicia Mosquera Torre; Laura Bao Pérez; Giovanni Marconi; Alessandro Isidori; Manuel Mateo Pérez Encinas; Giovanni Martinelli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13112639
Contributors: Dr. Massimo Martino ; Filippo Antonio Canale; Caterina Alati; Iolanda Donatella Vincelli; Tiziana Moscato; Gaetana Porto; Barbara Loteta; Virginia Naso; Massimiliano Mazza; Fabio Nicolini et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia

International Journal of Molecular Sciences
2021-02-21 | Journal article
DOI: 10.3390/ijms22042150
Contributors: Massimo Martino; Caterina Alati; Filippo Antonio Canale; Gerardo Musuraca; Giovanni Martinelli; Claudio Cerchione
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A WEE1 family business: Regulation of mitosis, cancer progression, and therapeutic target

Journal of Hematology and Oncology
2020 | Journal article
DOI: 10.1186/s13045-020-00959-2
EID:

2-s2.0-85091473499

Part of ISSN: 17568722
Contributors: Ghelli Luserna Di Rorà, A.; Cerchione, C.; Martinelli, G.; Simonetti, G.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

ABVD vs BEACOPP escalated in advanced-stage Hodgkin’s lymphoma: Results from a multicenter European study

American Journal of Hematology
2020 | Journal article
DOI: 10.1002/ajh.25871
EID:

2-s2.0-85087183944

Part of ISSN: 10968652 03618609
Contributors: Mondello, P.; Musolino, C.; Dogliotti, I.; Bohn, J.-P.; Cavallo, F.; Ferrero, S.; Botto, B.; Cerchione, C.; Nappi, D.; De Lorenzo, S. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

Cell Transplantation
2020 | Journal article
DOI: 10.1177/0963689720968749
EID:

2-s2.0-85094838080

Part of ISSN: 15553892 09636897
Contributors: Ravaioli, S.; Tebaldi, M.; Fonzi, E.; Angeli, D.; Mazza, M.; Nicolini, F.; Lucchesi, A.; Fanini, F.; Pirini, F.; Tumedei, M.M. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

Acute leukemias in 2020: State of the art

Minerva Medica
2020 | Journal article
DOI: 10.23736/S0026-4806.20.07049-4
EID:

2-s2.0-85097003601

Part of ISSN: 18271669 00264806
Contributors: Cerchione, C.; Martinelli, G.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Allogenic stem cell transplantation in multiple myeloma: Dead or alive and kicking?

Panminerva Medica
2020 | Journal article
DOI: 10.23736/S0031-0808.20.04142-7
EID:

2-s2.0-85100224070

Part of ISSN: 18271898 00310808
Contributors: MARTINO, M.; PAVIGLIANITI, A.; GENTILE, M.; MARTINELLI, G.; CERCHIONE, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

Anti-cancer drugs
2020 | Journal article
DOI: 10.1097/CAD.0000000000000850
EID:

2-s2.0-85076062617

Part of ISSN: 14735741
Contributors: Cerchione, C.; Martinelli, G.; Pedatella, S.; De Nisco, M.; Pugliese, N.; Manfra, M.; Marra, N.; Ronconi, S.; De Giorgi, U.; Altini, M. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

An Innovative Organization Model to Face Risks Reduction Challenges in an Italian Cancer Center during the COVID-19 Pandemic: A Risk Reduction Estimation Study

SSRN
2020 | Other
DOI: 10.2139/ssrn.3619804
EID:

2-s2.0-85110132562

Part of ISSN: 15565068
Contributors: Gentili, N.; Roncadori, A.; Massa, I.; Florescu, C.; Bertoni, L.; Galardi, F.; Bucchi, L.; Grossi, V.; Vespignani, R.; Cerchione, C. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Autologous stem cell transplantation in multiple myeloma

Panminerva Medica
2020 | Journal article
DOI: 10.23736/S0031-0808.20.04114-2
EID:

2-s2.0-85100224236

Part of ISSN: 18271898 00310808
Contributors: RICCIUTI, G.; FALCONE, A.; CASCAVILLA, N.; MARTINELLI, G.; CERCHIONE, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pretreated Multiple Myeloma: Old/New in Novel Agents' Era

American Journal of Hematology
2020 | Journal article
WOSUID: WOS:000577607300008
Contributors: Cerchione, Claudio; Catalano, Lucio; Martinelli, Giovanni
Source: check_circle
Web of Science Researcher Profile Sync

Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily PreTreated Multiple Myeloma: Old/New in the Novel Agents' Era

Clinical Lymphoma Myeloma and Leukemia
2020 | Journal article
WOSUID: WOS:000564055100339
Contributors: Cerchione, Claudio; Catalano, Lucio; Nappi, Davide; Rocco, Stefano; Palmieri, Salvatore; Pareto, Anna Emanuele; Musuraca, Gerardo; Lucchesi, Alessandro; Pane, Fabrizio; Ferrara, Felicetto et al.
Source: check_circle
Web of Science Researcher Profile Sync

Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report

Medicine
2020 | Journal article
DOI: 10.1097/MD.0000000000021440
EID:

2-s2.0-85090180983

Part of ISSN: 15365964
Contributors: Cerchione, C.; Nappi, D.; Musuraca, G.; Lucchesi, A.; Cimmino, I.; Pane, F.; De Renzo, A.; Martinelli, G.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 3)‎

Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma

American Journal of Hematology
2020 | Journal article
WOSUID: WOS:000577607300007
Contributors: Cerchione, Claudio; Martinelli, Giovanni; Catalano, Lucio
Source: check_circle
Web of Science Researcher Profile Sync

Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma

Clinical Lymphoma Myeloma and Leukemia
2020 | Journal article
WOSUID: WOS:000564055100340
Contributors: Cerchione, Claudio; Catalano, Lucio; Nappi, Davide; Pareto, Anna Emanuele; Musuraca, Gerardo; Lucchesi, Alessandro; Pane, Fabrizio; Martinelli, Giovanni
Source: check_circle
Web of Science Researcher Profile Sync

Combined oral fentanyl citrate and midazolam as premedication for bone marrow aspiration and biopsy in patients with hematological malignancies: A randomized, controlled and patient-blinded clinical trial

Journal of Clinical Medicine
2020 | Journal article
DOI: 10.3390/jcm9020395
EID:

2-s2.0-85114281840

Part of ISSN: 20770383
Contributors: Cerchione, C.; Martinelli, G.; Picardi, M.; Pugliese, N.; Nappi, D.; Casoria, A.; Gravetti, A.; Cangini, D.; Giannini, M.B.; Ronconi, S. et al.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
grade
Preferred source (of 2)‎

Contribution of Macrophages and T Cells in Skeletal Metastasis

Cancers
2020 | Journal article
DOI: 10.3390/CANCERS12041014
WOSUID: WOS:000535587400242
Contributors: Mendoza-Reinoso, Veronica; McCauley, Laurie K.; Fournier, Pierrick G. J.
Source: check_circle
Web of Science Researcher Profile Sync

cPX-351 daunorubicin-cytarabine liposome: A novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia

Minerva Medica
2020 | Journal article
DOI: 10.23736/S0026-4806.20.07017-2
EID:

2-s2.0-85097003783

Part of ISSN: 18271669 00264806
Contributors: Cafaro, A.; Giannini, M.B.; Silimbani, P.; Cangini, D.; Masini, C.; Di Rorà, A.G.L.; Simonetti, G.; Martinelli, G.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

Current and future perspectives of maintenance therapy in multiple myeloma

Panminerva Medica
2020 | Journal article
DOI: 10.23736/S0031-0808.20.04117-8
EID:

2-s2.0-85100224465

Part of ISSN: 18271898 00310808
Contributors: NAGARAJAN, C.; TAN, M.S.; CHEN, Y.; MARTINELLI, G.; CERCHIONE, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier

current strategies for detection and approach to measurable residual disease in acute myeloid leukemia

Minerva Medica
2020 | Journal article
DOI: 10.23736/S0026-4806.20.07016-0
EID:

2-s2.0-85097002991

Part of ISSN: 18271669 00264806
Contributors: Palmieri, R.; Buccisano, F.; Maurillo, L.; Del Principe, M.I.; Paterno, G.; Venditti, A.; Martinelli, G.; Cerchione, C.
Source: Self-asserted source
Claudio Cerchione via Scopus - Elsevier
Items per page:
Page 1 of 6

Peer review (66 reviews for 26 publications/grants)

Review activity for Annals of research in oncology. (1)
Review activity for BMC cancer (1)
Review activity for Bone marrow transplantation (1)
Review activity for Cancer medicine. (2)
Review activity for Cancer. (1)
Review activity for Cancers. (2)
Review activity for Clinical drug investigation. (1)
Review activity for Clinical hematology international. (1)
Review activity for Communications medicine. (2)
Review activity for Current medical research and opinion. (3)
Review activity for Drugs (6)
Review activity for EClinicalMedicine. (2)
Review activity for EJHaem. (1)
Review activity for Expert review of anticancer therapy (1)
Review activity for Expert review of hematology (2)
Review activity for Expert review of precision medicine and drug development. (1)
Review activity for Future oncology. (4)
Review activity for HemaSphere. (6)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of clinical medicine. (3)
Review activity for Journal of international medical research. (4)
Review activity for Journal of medical economics. (6)
Review activity for Journal of translational medicine. (2)
Review activity for Supportive care in cancer. (7)
Review activity for Supportive care in cancer. (4)
Review activity for World journal of surgical oncology (1)
How many people are using ORCID?